The Medical University of Vienna is a public university located in Vienna, Austria. It is the direct successor to the faculty of medicine at the University of Vienna, founded in 1365 by Rudolf IV, Duke of Austria.

During the past decade, Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria" #1 collaborator was "Attoquant Diagnostics" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria" are "CKD-MBD - Chronic Kidney Disease Mineral and Bone Disorder" (1 trials), "Chronic Hepatitis C-virus Infection" (1 trials), "Chronic Kidney Disease" (1 trials), "Chronic Kidney Disease stage3" (1 trials) and "Chronic Kidney Disease stage4" (1 trials). Many other conditions were trialed in "Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria" in a lesser frequency.

Most popular intervention types in "Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria" are "Drug" (5 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aliskiren" (1 trials), "Candesartan" (1 trials), "Cholecalciferol" (1 trials), "Empagliflozin 10 MG [Jardiance]" (1 trials) and "Empagliflozin 10 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Department of Internal Medicine III, Division of Nephrology and Dialysis, Medical University of Vienna, Austria, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".